PolyMedix Announces Presentation of Four Abstracts at ECCMID 2011 Meeting
May 5, 2011 11:00 UTC
RADNOR, Pa.--(BUSINESS WIRE)-- PolyMedix, Inc. (OTC BB: PYMX), an emerging biotechnology company focused on developing new therapeutic drugs to treat life-threatening infectious diseases and acute cardiovascular disorders, today announced the acceptance of four presentations on the Company’s lead antibiotic drug candidate, PMX-30063, at the European Congress of Clinical Microbiology and Infectious Diseases (ECCMID). ECCMID attracts more than ten thousand experts each year, covering key topics of infectious disease including diagnosis, prevention, pathogenesis, treatment, and antibiotic resistance. The meeting will take place in Milan, Italy from May 7-10, 2011.
The following abstracts will be presented:
New Antimicrobial Drugs in the Pipeline
Oral Presentation
Abstract Title: Investigation of Potential Mechanisms Underlying Transient Parasthesia associated with PMX-30063 Administration in Human Subjects
Presentation Date/Time: Saturday, May 7, 2011, 18:18 – 18:30
Presenter: B. Korczak (Radnor, PA)
Abstract Control Number: O 97
New Targets for New Antimicrobials
Poster Session
Abstract Title: In Vitro Activity Profile of PMX-30063 Against Recent Clinical Isolates of Gram-positive and Gram-negative Pathogens
Presentation Date/Time: Sunday, May 8, 2011, 13:30 – 14:30
Presenter: B. Korczak (Radnor, PA)
Abstract Control Number: P 1168
New Antimicrobials: Preclinical and Clinical Studies
Poster Session
Abstract Title: A Phase 1 Trial to Evaluate the Tolerability, Safety and Pharmacokinetics of Multi-dose Intravenous Regiments of PMX-30063
Presentation Date/Time: Monday, May 9, 2011, 12:30 – 13:30
Presenter: B. Korczak (Radnor, PA)
Abstract Control Number: P 1515
New Antimicrobials: Preclinical and Clinical Studies
Poster Session
Abstract Title: Understanding Neuronal Effects in Multi Dose – Phase 1 Clinical Study
Presentation Date/Time: Monday, May 9, 2011, 12:30 - 13:30
Presenter: B. Korczak (Radnor, PA)
Abstract Control Number: P 1514 |
